BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1888 related articles for article (PubMed ID: 12571209)

  • 41. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
    Hannah A; Scott AM; Tochon-Danguy H; Chan JG; Akhurst T; Berlangieri S; Price D; Smith GJ; Schelleman T; McKay WJ; Sizeland A
    Ann Surg; 2002 Aug; 236(2):208-17. PubMed ID: 12170026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses.
    Anzai Y; Carroll WR; Quint DJ; Bradford CR; Minoshima S; Wolf GT; Wahl RL
    Radiology; 1996 Jul; 200(1):135-41. PubMed ID: 8657901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.
    Inohara H; Enomoto K; Tomiyama Y; Yoshii T; Osaki Y; Higuchi I; Inoue T; Hatazawa J
    Acta Otolaryngol; 2009 Aug; 129(8):893-9. PubMed ID: 18839385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
    Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
    Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
    Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF
    Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of FDG PET on the management of occult primary head and neck tumours.
    Wong WL; Saunders M
    Clin Oncol (R Coll Radiol); 2003 Dec; 15(8):461-6. PubMed ID: 14690001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A; Xue J; Hu M; Zheng J; Wang X
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Doo H; Lee H; Lee JH; Cho KJ; Choi SH; Nam SY; Roh JL
    Oral Oncol; 2011 May; 47(5):376-80. PubMed ID: 21470899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
    Stuckensen T; Kovács AF; Adams S; Baum RP
    J Craniomaxillofac Surg; 2000 Dec; 28(6):319-24. PubMed ID: 11465137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.
    Yao M; Luo P; Hoffman HT; Chang K; Graham MM; Menda Y; Tan H; Buatti JM
    Am J Clin Oncol; 2007 Jun; 30(3):264-70. PubMed ID: 17551303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
    Li LF; Zhou SH; Zhao K; Wang SQ; Wu QL; Fan J; Cheng KJ; Ling L
    Cancer Biother Radiopharm; 2008 Dec; 23(6):701-14. PubMed ID: 19317609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.
    Sakamoto H; Nakai Y; Ohashi Y; Matsuda M; Sakashita T; Nasako Y; Kitayama H; Kawabe J; Okamura T; Ochi H
    Acta Otolaryngol Suppl; 1998; 538():254-60. PubMed ID: 9879431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT].
    Dresel S; Schwenzer K; Brinkbäumer K; Schmid R; Szeimies U; Pöpperl G; Hahn K
    Nuklearmedizin; 2001 Oct; 40(5):172-8. PubMed ID: 11727630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
    Pellini R; Manciocco V; Turri-Zanoni M; Vidiri A; Sanguineti G; Marucci L; Sciuto R; Covello R; Sperduti I; Kayal R; Anelli V; Pichi B; Mercante G; Spriano G
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1834-9. PubMed ID: 25150165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK; Abouzied ME
    Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of residual head and neck squamous cell carcinoma after (chemo)radiotherapy: a pilot study assessing the value of diffusion-weighted magnetic resonance imaging as an adjunct to PET-CT using
    Noij DP; Jagesar VA; de Graaf P; de Jong MC; Hoekstra OS; de Bree R; Castelijns JA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):296-305.e2. PubMed ID: 28539202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 95.